Subcutaneous Entyvio hits Crohns primary endpoint misses secondary
If approved the drug could have huge benefits for patients as they could selfadminister their therapy from home.
View ArticleTakedas SC Entyvio meets primary endpoint in Crohns Disease
At the European Crohns and Colitis Organization ECCO congress in Vienna Austria Takeda announced the subcutaneous SC formulation of Entyvio...Read More...The post Takedas SC Entyvio meets primary...
View ArticleInnovate Biopharmaceuticals Announces Shareholder Approval of All Proposals...
Closing of this transformative transaction expected in early Q2 2020 upon completion of remaining closing conditions and receipt of regulatory approval in IsraelRALEIGH NC ACCESSWIRE February 18 2020...
View ArticleJanssen shows off Phase 3b interim data for Stelara in Crohns disease...
Janssen shows off Phase 3b interim data for Stelara in Crohns disease httpbit.ly38CXzf3 pharma pic.twitter.com4FdH8ywlLu
View ArticleJanssen shows off Phase 3b interim data for Stelara in Crohn's disease
Janssen has revealed new interim Phase 3b data from a study investigating the efficacy of Stelara ustekinumab in the treatment of moderate to severe Crohns disease CD.Patients were given a 6mgkg...
View ArticleFDA Grants Priority Review to Genentechs Tecentriq Monotherapy as Firstline...
ÂGenentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced that the U.S. Food and Drug Administration FDA has accepted the companys supplemental Biologics License Application sBLA...
View ArticleInnovate Biopharmaceuticals Announces Acceptance of Three Abstracts for the...
Highlighting Larazotide&39;s Effect across the GutVascular Barrier a Fundamental Disease Mechanism in a Variety of Autoimmune and Inflammatory DiseasesRALEIGH NC ACCESSWIRE February 19 2020...
View ArticleNew Institute Launched to Ensure the U.S. Healthcare System Is Ready for Gene...
Industry leaders patient advocates researchers unite to maximize the incredible potential of transformative gene therapies The Institute for Gene Therapies IGT launched today with a focus on advocating...
View ArticleHealthline Together Announces Migraine Healthline App for iOS and Android
New Social Network Empowers Living Beyond Migraines Through Compassion Support and KnowledgeHealthline Media today announced the launch of a new application Migraine Healthline designed to help the 39...
View ArticleCrohn's Boosts Risk of Death From Colorectal Cancer
>MedPage Today Compared with the general population individuals with Crohn's disease CD are at increased risk of developing and dying of colorectal cancer CRC according to the first populationbased...
View ArticleProtected Can the symptoms of Crohns disease be eased by marijuana
There is no excerpt because this is a protected post.
View ArticleCan the symptoms of Crohns disease be eased by marijuana
Symptoms of Crohn&8217;s disease Crohn&8217;s disease is identified as one type of IBD Inflammatory bowel disease. This disease is chronic and results in the inflammation... Read More &8594;
View ArticleMatrix Metalloproteinase 9 Pipeline Review H2 2019 Published by Global...
Matrix Metalloproteinase 9 Pipeline Review H2 2019SummaryMatrix Metalloproteinase 9 Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35 Matrix metallopeptidase 9...
View ArticleHuman medicines European public assessment report EPAR Stelara ustekinumab...
Human medicines European public assessment report EPAR Stelara ustekinumab PsoriasisArthritis PsoriaticCrohn Disease Date of authorisation 15012009 Revision 31 Status Authorised
View ArticleConnect Biopharma Enhances its Intellectual Property Estate for CBP307 a...
Novel nextgeneration S1P1 agonist currently in Phase 2 clinical development for treatment of inflammatory bowel disease SAN DIEGO and TAICANG China Feb. 25 2020 PRNewswire Connect Biopharma a...
View ArticleAbivax Includes First Patient in U.S. Phase 12 Clinical Trial of ABX196 to...
DGAPNews ABIVAX Key words Study26.02.2020 1800 The issuer is solely responsible for the content of this announcement.Abivax Includes First Patient in U.S. Phase 12 Clinical Trial of ABX196 to Treat...
View ArticleHuman medicines European public assessment report EPAR Remsima infliximab...
Human medicines European public assessment report EPAR Remsima infliximab Arthritis PsoriaticSpondylitis AnkylosingColitis UlcerativePsoriasisCrohn DiseaseArthritis Rheumatoid Date of authorisation...
View ArticleNextgeneration Targeted Cytokine Therapy to be Explored on Advancements Series
Discover the latest innovations in oncology and inflammatory disease treatment.JUPITER Fla. PRWEB February 27 2020 An upcoming episode of Advancements with Ted Danson scheduled to broadcast 2Q2020 will...
View ArticleTakeda Receives Positive CHMP Opinion for Subcutaneous Formulation of...
ÂIf approved the additional treatment modality will provide more options for how patients in Europe receive the gutselective biologic vedolizumab Recommendation brings vedolizumab one step closer to...
View ArticleTakeda's subcutaneous vedolizumab nabs CHMP nod for maintenance of ulcerative...
Takeda's subcutaneous vedolizumab nabs CHMP nod for maintenance of ulcerative colitis and Crohn's httpbit.ly2PwjKvS pharma pic.twitter.comKGv6oQCB5h
View Article